A new mouse expressing human Fcγ receptors to better predict therapeutic efficacy of human anti-cancer antibodies

Leukemia. 2018 Feb;32(2):547-549. doi: 10.1038/leu.2017.293. Epub 2017 Sep 19.

Authors

E Casey^{1

2}, S Bournazos³, G Mo², P Mondello², K S Tan⁴, J V Ravetch³, D A Scheinberg^{1

2

5}

Affiliations

¹ Gerstner Sloan Kettering Graduate School, Memorial Sloan Kettering, New York, NY, USA.
² Molecular Pharmacology Program, Memorial Sloan Kettering, New York, NY, USA.
³ Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY, USA.
⁴ Epidemiology & Biostatistics, Memorial Sloan Kettering, New York, NY, USA.
⁵ Weill Cornell Medicine, New York, NY, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Antibodies, Monoclonal / immunology*
Humans
Mice
Neoplasms / immunology*
Neutrophils / immunology
Receptors, IgG / immunology*

Substances

Antibodies, Monoclonal
Receptors, IgG

Grants and funding